Skip to main content
. 2021 Jan 27;14(3):101012. doi: 10.1016/j.tranon.2021.101012

Fig. 3.

Fig 3

Major mechanisms of resistance to PARPi. Top panel: Restoration of HR by acquisition of secondary mutations in HR genes, or in NHEJ genes. Bottom left panel: drug efflux pumps can decrease intracellular concentration of drugs such as PARPi. Bottom right: Stabilization of forks allow rescue even in the absence of other cellular components, and reverse the synthetic lethality, thus rendering cells resistant to PARPinhibition.